Search hospitals > Colorado > Englewood
Swedish Medical Center
Claim this profileEnglewood, Colorado 80113
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Lymphoma
Conducts research for Melanoma
341 reported clinical trials
6 medical researchers
Summary
Swedish Medical Center is a medical facility located in Englewood, Colorado. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Lymphoma, Melanoma and other specialties. Swedish Medical Center is involved with conducting 341 clinical trials across 460 conditions. There are 6 research doctors associated with this hospital, such as Nicholas DiBella, Michael Pearlman, MD, Keren Sturtz, and Donald Frei, MD.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder6 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
103 reported clinical trials
193 drugs studied
Michael Pearlman, MDColorado Neurological Institute1 year of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
4 reported clinical trials
6 drugs studied
Keren SturtzSCL Health Lutheran Medical Center10 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
4 reported clinical trials
14 drugs studied
Donald Frei, MDRadiology Imaging Associates4 years of reported clinical research
Studies Intracranial Aneurysm
Studies Pararenal Aneurysms
2 reported clinical trials
3 drugs studied
Clinical Trials running at Swedish Medical Center
Lung Cancer
Melanoma
Bladder Cancer
Cutaneous Melanoma
Esophageal cancer
Lymphoma
Breast Cancer
Prostate Cancer
Colorectal Cancer
Stomach Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Swedish Medical Center?
Swedish Medical Center is a medical facility located in Englewood, Colorado. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Lymphoma, Melanoma and other specialties. Swedish Medical Center is involved with conducting 341 clinical trials across 460 conditions. There are 6 research doctors associated with this hospital, such as Nicholas DiBella, Michael Pearlman, MD, Keren Sturtz, and Donald Frei, MD.
Where is Swedish Medical Center located?
Swedish Medical Center, situated at 501 East Hampden Avenue, Englewood, CO 80113, is a Level I trauma center and acute care hospital. It houses 408 licensed beds. The hospital provides comprehensive services such as cancer care, cardiovascular care, neurological care, orthopedic care, and trauma care.
Who should I call to ask about financial aid or insurance network?
**Swedish Medical Center Financial and Billing Assistance:**
- **Financial Assistance:** Contact the Corporate Business Office at 206-320-5300 or 877-406-0438, available Monday to Friday, 8 am to 6 pm.
- **Billing Questions:** For hospital bills, call 1-877-406-0438. For Swedish Medical Group bills, call 1-888-294-9333.
- **Main Switchboard Numbers:**
- First Hill Campus (Seattle): 206-386-6000
- Cherry Hill Campus (Seattle): 206-320-2000
- Ballard Campus: 206-782-2700
- Issaquah: 425-313-4000
- Edmonds: 425-640-4000
- Mill Creek and Redmond: 206-386-6000
What insurance does Swedish Medical Center accept?
Swedish Medical Center accepts a wide range of insurance plans, including but not limited to Medicare, Medicaid, Molina Healthcare, Multiplan/PHCS, Premera Blue Cross, Providence Health Assurance, Regence Blue Shield, TRICARE, and most Blue Cross Blue Shield out-of-state plans. They are also in-network with specific Aetna insurance plans such as Aetna Whole Health, Aetna Standard Plans, and Aetna Medicare, among others. Additionally, they accept various Medicare Advantage plans including Kaiser Permanente Medicare Advantage, AARP Medicare Advantage, UHC Dual Complete, Wellcare, Molina Medicare Choice Care, and Providence Medicare Advantage plans.
What awards or recognition has Swedish Medical Center received?
Swedish Medical Center, located in Englewood, Colorado, is distinguished by the America's 100 Best Hospitals Award™ and America's 250 Best Hospitals Award™. It serves as a Level I trauma center and is the Rocky Mountain Region's referral center for neurotrauma. Additionally, it is recognized by the Joint Commission for its advanced stroke care, the first in the region.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.